You can access any of the podium or poster presentations’ abstracts by searching for it below. For the 2026 FIP world congress in Montreal, presentations and summaries from invited speakers are available below, while abstracts are published in the Pharmacy Education Journal (PEJ) here.
Export this Abstract | Print this Abstract |
Add to my preferred Abstracts list |
My preferred Abstracts list (34) |
Back to Search
L-serine-modified polyamidoamine dendrimer as a highly potent renal targeting drug carrier
- At: PSWC2020 (2020)
- Type: Poster
- By: KATSUMI, Hidemasa (Kyoto Pharmaceutical University, Biopharmaceutics, Japan)
- Co-author(s): Hidemasa Katsumi: Biopharmaceutis, Kyoto Pharmaceutical University, Kyoto, Japan
Satoru Matsuura: Biopharmaceutis, Kyoto Pharmaceutical University, Kyoto, Japan
Masaki Morishita: Biopharmaceutis, Kyoto Pharmaceutical University, Kyoto, Japan
Toshiyasu Sakane: Biopharmaceutis, Kyoto Pharmaceutical University, Kyoto, Japan;Pharmaceutical Technology, Kobe Pharmaceutical University, Kobe, Japan
Akira Yamamoto: Biopharmaceutis, Kyoto Pharmaceutical University, Kyoto, Japan - Abstract:
Background
Effective delivery of drug carriers selectively to the kidney is challenging because of their uptake by the reticuloendothelial system in the liver and spleen. This limits effective treatment of kidney diseases and results in side effects.Purpose
To address this issue, we synthesized L-serine (Ser)-modified polyamidoamine dendrimer.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 23 September 2026